Pinnacle Financial Partners Inc Amgen Inc Transaction History

Pinnacle Financial Partners Inc

$4.66 Billion
Q2 2024

A detailed history of Pinnacle Financial Partners Inc transactions in Amgen Inc stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 57,422 shares of AMGN stock, worth $18.4 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

57,422

Previous 57,518 0.17%

Holding current value

$18.4 Million

Previous $16.4 Million 9.71%

% of portfolio

0.39%

Previous 0.36%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $25,224 - $30,653	-96 Reduced 0.17%	57,422 $17.9 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $54,042 - $65,236	201 Added 0.35%	57,518 $16.4 Million
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $99,467 - $112,210	-389 Reduced 0.67%	57,317 $16.5 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $297,582 - $369,457	1,361 Added 2.42%	57,706 $15.5 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $25,069 - $29,644	-117 Reduced 0.21%	56,345 $12.5 Million
Q1 2023 Apr 26, 2023	SELL	$225.79 - $275.2 $1.32 Million - $1.6 Million	-5,824 Reduced 9.35%	56,462 $13.6 Million
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $1.42 Million - $1.8 Million	6,180 Added 11.01%	62,286 $16.4 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $440,166 - $496,427	-1,961 Reduced 3.38%	56,106 $12.6 Million
Q2 2022 Jul 29, 2022	SELL	$230.71 - $256.74 $21,456 - $23,876	-93 Reduced 0.16%	58,067 $14.1 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $126,080 - $139,477	-575 Reduced 0.98%	58,160 $14.1 Million
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $5.73 Million - $6.56 Million	-28,836 Reduced 32.93%	58,735 $13.2 Million
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $737,850 - $864,481	3,476 Added 4.13%	87,571 $18.6 Million
Q2 2021 Jul 21, 2021	BUY	$233.58 - $259.14 $458,283 - $508,432	1,962 Added 2.39%	84,095 $20.5 Million
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $4.31 Million - $5.03 Million	19,439 Added 31.01%	82,133 $20.4 Million
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $2.24 Million - $2.66 Million	-10,331 Reduced 14.15%	62,694 $14.4 Million
Q3 2020 Oct 27, 2020	BUY	$234.65 - $260.95 $2.16 Million - $2.4 Million	9,197 Added 14.41%	73,025 $18.6 Million
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $3.36 Million - $4.12 Million	16,992 Added 36.28%	63,828 $15.1 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $354,821 - $470,589	1,947 Added 4.34%	46,836 $9.5 Million
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $463,375 - $595,596	2,449 Added 5.77%	44,889 $10.8 Million
Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $368,590 - $441,648	2,117 Added 5.25%	42,440 $8.21 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $186,370 - $218,468	-1,118 Reduced 2.7%	40,323 $7.43 Million
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $515,117 - $580,650	2,848 Added 7.38%	41,441 $7.87 Million
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $396,761 - $463,148	2,224 Added 6.12%	38,593 $7.51 Million
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $117,288 - $132,227	633 Added 1.77%	36,369 $7.54 Million
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $454,312 - $510,291	2,736 Added 8.29%	35,736 $6.6 Million
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $1.24 Million - $1.45 Million	-7,309 Reduced 18.13%	33,000 $5.63 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $648,997 - $725,128	3,845 Added 10.54%	40,309 $7.01 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $6.1 Million - $6.96 Million	36,464	36,464 $6.8 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.

Account

Pinnacle Financial Partners Inc Amgen Inc Transaction History